| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/31/1997 | WO1997027287A1 Cauliflower floral meristem identity genes and methods of using same |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027284A2 Human rad50 and septin-2 genes and methods of use |
| 07/31/1997 | WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | WO1997027219A1 Methods for purification and use of erythropoietin binding protein |
| 07/31/1997 | WO1997027218A1 Method for evaluating and affecting male fertility |
| 07/31/1997 | WO1997027217A1 Peptides and uses thereof for therapy of celiac diseases |
| 07/31/1997 | WO1997027216A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | WO1997027215A1 Nucleotide and amino acid sequences of t. pallidum rare outer membrane protein |
| 07/31/1997 | WO1997027213A1 Methods for screening for transdominant effector peptides and rna molecules |
| 07/31/1997 | WO1997027212A1 Methods for screening for transdominant intracellular effector peptides and rna molecules |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997027207A1 A plant nuclear scaffold attachment region which increases gene expression |
| 07/31/1997 | WO1997026920A2 Conjugate for differentiating between diseased and healthy tissues |
| 07/31/1997 | WO1997026916A1 Obesity protein analog compounds and formulations thereof |
| 07/31/1997 | WO1997026913A1 A POLYPEPTIDE FROM LUNG EXTRACT WHICH BINDS AMYLOID-β PEPTIDE |
| 07/31/1997 | WO1997026911A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | WO1997026907A1 Novel administration of thrombopoietin |
| 07/31/1997 | WO1997026906A1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 07/31/1997 | WO1997026905A1 A synthetic macromolecular channel assembly for transport of chloride ions through epithelium |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/31/1997 | WO1996040772A3 Agonist peptide dimers |
| 07/31/1997 | DE19545351C1 Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie Eukaryotic cells with hybrid receptor and thereby controllable gene construct, to processes for their preparation and use of these cells for gene therapy |
| 07/31/1997 | CA2573196A1 Methods for purification and use of erythropoietin binding protein |
| 07/31/1997 | CA2245002A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | CA2244881A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244372A1 Methods for identifying inhibitors of rna viruses |
| 07/31/1997 | CA2244222A1 Methods for screening for transdominant effector peptides and rna molecules |
| 07/31/1997 | CA2244147A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | CA2243969A1 Plant tissue/stage specific promoters for regulated expression of transgenes in plants |
| 07/31/1997 | CA2243850A1 Raspberry promoters for expression of transgenes in plants |
| 07/31/1997 | CA2243533A1 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | CA2243497A1 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2242417A1 Novel administration of thrombopoietin |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | CA2196238A1 Homogeneous isolate of urabe mumps virus and vaccines containing the isolate |
| 07/30/1997 | EP0786522A2 Enzymatic RNA molecules for treatment of stenotic conditions |
| 07/30/1997 | EP0786521A1 Nucleic acid encoding PspA |
| 07/30/1997 | EP0786520A1 Method for the production of biological active beta-NGF by genetic engineering |
| 07/30/1997 | EP0786519A2 Staphylococcus aureus polynucleotides and sequences |
| 07/30/1997 | EP0786474A1 A recombinant buman factor VIII derivative |
| 07/30/1997 | EP0786473A2 Basic protein composition, basic peptide composition and application thereof |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786469A2 Nucleic acid ligands |
| 07/30/1997 | EP0786256A2 Obesity protein formulations |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0786088A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 07/30/1997 | EP0786084A1 Method for screening compositions |
| 07/30/1997 | EP0786009A1 Process for bacterial production of heterologous polypeptides with disulphide bonds |
| 07/30/1997 | EP0786003A1 Insect viruses and their uses in protecting plants |
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 07/30/1997 | EP0786001A1 Chemokine-like proteins and methods of use |
| 07/30/1997 | EP0786000A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/30/1997 | EP0785997A2 Delivery system |
| 07/30/1997 | EP0785996A1 Nucleotide sequences and process for amplifying and detection of hepatitis b virus |
| 07/30/1997 | EP0785992A1 Conditional transformation of genetically engineered cells |
| 07/30/1997 | EP0785991A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 07/30/1997 | EP0785990A1 Method for stimulating profileration of colon cells using pomc 76-103 |
| 07/30/1997 | EP0785951A1 Tc or re radiolabelled somatostatin analogs |
| 07/30/1997 | EP0785950A2 Keratinocyte growth factor analogs |
| 07/30/1997 | EP0785949A1 Method for purifying keratinocyte growth factors |
| 07/30/1997 | EP0785948A1 Analogs of keratinocyte growth factor |
| 07/30/1997 | EP0785947A1 Peptides endowed with antiinflammatory activity |
| 07/30/1997 | EP0785946A1 Materials for the production of nanometer structures and use thereof |
| 07/30/1997 | EP0785920A1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 07/30/1997 | EP0785799A1 Process for production of inhibited forms of activated blood factors |
| 07/30/1997 | EP0785793A1 Allosteric modulators of the nmda receptor |
| 07/30/1997 | EP0785792A1 Treatment of ovarian estrogen dependent conditions |
| 07/30/1997 | EP0785716A1 Cytokine designated lerk-6 |
| 07/30/1997 | EP0604495B1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |
| 07/30/1997 | EP0476044B1 Use of IGF1 or IGF2 for the manufacture of a medicament in the treatment of amyotrophic lateral sclerosis |
| 07/30/1997 | CN1155931A Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155903A T cell antigen receptor V region proteins and methods of preparation thereof |
| 07/30/1997 | CN1155549A Non-densatured extraction of medical collagen protein and denatured application |
| 07/30/1997 | CN1155548A £Beta-9 glutamic acid, beta-10 aspartic acid| human insulin |
| 07/30/1997 | CN1155547A Production of MT |
| 07/29/1997 | US5652357 Nucleic acids for the detection of the Bak polymorphism in human platelet membrane glycoprotein IIb |
| 07/29/1997 | US5652354 Stamen-selective promoters |
| 07/29/1997 | US5652353 DNAs encoding tumor necrosis factor-α muteins |
| 07/29/1997 | US5652352 Afamin: a human serum albumin-like gene |
| 07/29/1997 | US5652346 Dicarboxylic acid oxidation products |
| 07/29/1997 | US5652343 Method for purification of L-selectin ligands |
| 07/29/1997 | US5652342 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 07/29/1997 | US5652340 Matrix-associating DNA-binding protein, nucleic acids encoding the same and methods for detecting the nucleic acids |
| 07/29/1997 | US5652339 Method of producing reconstituted lipoproteins |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652337 OP-3-induced morphogenesis |
| 07/29/1997 | US5652333 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 07/29/1997 | US5652332 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/29/1997 | US5652235 Method of using spiro piperidines to promote the release of growth hormone |
| 07/29/1997 | US5652224 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652222 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |